Cases 21 - 30 of 861
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2023cv00877
Plaintiff:
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ANDERSON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv13680
Plaintiff:
JERRY ANDERSON and PHILISA J. ANDERSON
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KENNEDY v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv13282
Plaintiff:
ROBERT KENNEDY
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WOJNICKI v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04496
Plaintiff:
JAMES WOJNICKI
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Astellas Pharma, Inc. v. Sandoz Inc.
as 23-2032
Plaintiff / Appellant:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant / Appellee:
SANDOZ INC., PRINSTON PHARMACEUTICAL INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Defendant:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC and others
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HILL et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04125
Plaintiff:
REGINA HILL and BARRY HILL
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WORTHEN et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04163
Plaintiff:
GARY L. WORTHEN and LOLA E. WORTHEN
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03909
Plaintiff:
KENNETH W. WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
